Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours

Cancer Immunology, Immunotherapy

Volumn 62, Issue 8, 2013, Pages 1411-1419

  Szala, Agnieszka ^a   Sawicki, Sambor ^b   Swierzko, Anna St ^a   Szemraj, Janusz ^c   Sniadecki, Marcin ^b   Michalski, Mateusz ^a,d   Kaluzynski, Andrzej ^e   Lukasiewicz, Jolanta ^f   Maciejewska, Anna ^f   Wydra, Dariusz ^b   Kilpatrick, David C ^g   Matsushita, Misao ^h   Cedzynski, Maciej ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

^d UNIVERSITY OF LODZ   (Poland)

^e POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^f INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^g SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^h TOKAI UNIVERSITY   (Japan)

Author keywords

Benign ovarian tumours; FCN2 gene; FCN3 gene; Ficolin 2 (L ficolin); Ficolin 3 (H ficolin); Ovarian cancer

Indexed keywords

C REACTIVE PROTEIN; CA 125 ANTIGEN; CYTOSINE; FICOLIN; FICOLIN 2; FICOLIN 3; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; EXON; FCN2 GENE; FCN3 GENE; FEMALE; FICOLIN 2 BLOOD LEVEL; FICOLIN 3 BLOOD LEVEL; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENOTYPE; GLYCOPROTEINS; HUMANS; LECTINS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84880879871     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1445-3     Document Type: Article

References (42)

1. Kilpatrick DC, Chalmers JD (2012) Human L-ficolin (ficolin-2) and its clinical significance. J Biomed Biotechnol 2012:138797
2. Tsujimura M, Ishida C, Sagara Y, Miyazaki T, Murakami K, Shiraki H, Okochi K, Maeda Y (2001) Detection of serum thermolabile beta-2 macroglycoprotein (Hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by Aerococcus viridans. Clin Diagn Lab Immunol 8:454-459
3. Swierzko A, Lukasiewicz J, Cedzynski M, Maciejewska A, Jachymek W, Niedziela T, Matsushita M, Lugowski C (2012) New functional ligands for ficolin-3 among lipopolysaccharides of Hafnia alvei. Glycobiology 22:267-280
4. Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T (2005) Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 209:689-697
5. Honore C, Hummelshoj T, Hansen BE, Madsen HO, Eggleton P, Garred P (2007) The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum 56:1598-1607
6. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P (2005) Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 14:1651-1658
7. Hummelshoj T, Munthe-Fog L, Madsen HO, Garred P (2008) Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol 45:2508-2520
8. Herpers BL, Immink MM, de Jong BA, van Velzen-Blad H, de Jongh BM, van Hannen EJ (2006) Coding and non-coding polymorphisms in the lectin pathway activator L-ficolin gene in 188 Dutch blood bank donors. Mol Immunol 43:851-855
9. Cedzynski M, Nuytinck L, Atkinson AP, St Swierzko A, Zeman K, Szemraj J, Szala A, Turner ML, Kilpatrick DC (2007) Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clin Exp Immunol 150:99-104
10. Garred P, Honore C, Ma YJ, Rorvig S, Cowland J, Borregaard N, Hummelshoj T (2010) The genetics of ficolins. J Innate Immun 2:3-16
11. Munthe-Fog L, Hummelshoj T, Ma YJ, Hansen BE, Koch C, Madsen HO, Skjodt K, Garred P (2008) Characterization of a polymorphism in the coding sequence of FCN3 resulting in a ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 45:2660-2666
12. Munthe-Fog L, Hummelshoj T, Honore C, Madsen HO, Permin H, Garred P (2009) Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med 360:2637-2644
13. Schlapbach LJ, Thiel S, Kessler U, Ammann RA, Aebi C, Jensenius JC (2011) Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut 60:1438-1439
14. Michalski M, Szala A, Swierzko St A, Lukasiewicz J, Maciejewska A, Kilpatrick DC, Matsushita M, Domzalska-Popadiuk I, Borkowska-Klos M, Sokolowska A, Szczapa J, Lugowski C, Cedzynski M (2012) H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates. Immunobiology 217:730-737
15. Andersen JD, Boylan KL, Xue FS, Anderson LB, Witthuhn BA, Markowski TW, Higgins L, Skubitz AP (2010) Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis. Electrophoresis 31:599-610
16. Hummelshoj T, Munthe Fog L, Madsen HO, Sim RB, Garred P (2008) Comparative study of the human ficolins reveals unique features of ficolin-3 (Hakata antigen). Mol Immunol 45:1623-1632
17. Kuraya M, Matsushita M, Endo Y, Thiel S, Fujita T (2003) Expression of H-ficolin/Hakata antigen, mannose-binding lectin-associated serine protease (MASP)-1 and MASP-3 by human glioma cell line T98G. Int Immunol 15:109-117
18. Swierzko AS, Florczak K, Cedzynski M, Szemraj J, Wydra D, Bak-Romaniszyn L, Emerich J, Sulowska Z (2007) Mannan-binding lectin (MBL) in women with tumours of the reproductive system. Cancer Immunol Immunother 56:959-971
19. Leth-Larsen R, Floridon C, Nielsen O, Holmskov U (2004) Surfactant protein D in the female genital tract. Mol Hum Reprod 10:149-154
20. Hansen S, Selman L, Palaniyar N, Ziegler K, Brandt J, Kliem A, Jonasson M, Skjoedt MO, Nielsen O, Hartshorn K, Jørgensen TJ, Skjødt K, Holmskov U (2010) Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol 185(6096):6104
21. Kilpatrick DC, Fujita T, Matsushita M (1999) P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients. Immunol Lett 67:109-112
22. Szala A, Swierzko St A, Cedzynski M (2013) Cost-effective procedures for genotyping of human FCN2 gene single nucleotide polymorphisms. Immunogenetics 65:439-446
23. Li YL, Ye F, Hu Y, Lu WG, Xie X (2009) Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction. Anal Biochem 394:110-116
24. Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49
25. Bertenshaw GP, Yip P, Seshaiah P, Zhao J, Chen T-H, Wiggins WS, Mapes JP, Mansfield BC (2008) Multianalyte profiling of serum antigens and autoimmune and infectious disease molecule to identify biomarkers dysregulated in epithelial ovarian cancer. Cancer Epidemiol Biomarkers 17:2872-2881
26. Ytting H, Jensenius JC, Christensen IJ, Thiel S, Nielsen HJ (2004) Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol 39:674-679
27. Ytting H, Christensen IJ, Thiel S, Jensenius JC, Nielsen HJ (2005) Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality. Clin Cancer Res 11:1441-1446
28. Vazquez-Ortíz G, Ciudad CJ, Piña P, Vazquez K, Hidalgo A, Alatorre B, Garcia JA, Salamanca F, Peralta-Rodriguez R, Rangel A, Salcedo M (2005) Gene identification by cDNA arrays in HPV-positive cervical cancer. Arch Med Res 36:448-458
29. Arellano-Garcia ME, Li R, Liu X, Xie Y, Yan X, Lod JA, Hu S (2010) Indentification of tetranectin as a potential biomarker for metastatic oral cancer. Int J Mol Sci 11:3106-3121
30. Kilpatrick DC, McLintock LA, Allan EK, Copland M, Fujita T, Jordanides NE, Koch C, Matsushita M, Shiraki H, Stewart K, Tsujimura M, Turner ML, Franklin IM (2003) No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 134:279-284
31. Ameye L, Paesmans M, Thiel S, Jensenius JC, Aoun M (2012) M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy. Clin Exp Immunol 167:303-308
32. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, Ranganathan S, Michalopoulos GK (2006) Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44:1012-1024
33. Shi I, Hashemi Sadraei N, Duan ZH, Shi T (2011) Aberrant signaling pathways in squamous cell lung carcinoma. Cancer Inform 10:273-285
34. Schlapbach LJ, Aebi C, Hansen AG, Hirt A, Jensenius JC, Ammann RA (2009) H-ficolin serum concentration and susceptibility to fever and neutropenia in paediatric cancer patients. Clin Exp Immunol 157:83-89
35. Hefler-Frischmuth K, Hefler LA, Heinze G, Paseka V, Grimm C, Tempfer CB (2009) Serum C-reactive protein in the differential diagnosis of ovarian masses. Eur J Obstet, Gynecol Reprod Biol 147:65-68
36. Andersen T, Munthe-Fog L, Garred P, Jacobsen S (2009) Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J Rheumatol 36:757-759
37. Liu J, Ali MA, Shi Y, Zhao Y, Luo F, Yu J, Xiang T, Tang J, Li D, Hu Q, Ho W, Zhang X (2009) Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 4:235-244
38. Hoang TV, Toan NL, le Song H, Ouf EA, Bock CT, Kremsner PG, Kun JF, Velavan TP (2011) Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS ONE 6:e28113
39. Roy S, Biswas S, Saroha A, Sahu D, Das HR (2012) Enhanced expression and fucosylation of ficolin3 in plasma of RA patients. Clin Biochem 46:160-163
40. Sallenbach S, Thiel S, Aebi C, Otth M, Bigler S, Jensenius JC, Schlapbach LJ, Ammann RA (2011) Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 22:424-430
41. Ma YG, Cho MY, Zhao M, Park JW, Matsushita M, Fujita T, Lee BL (2004) Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem 279:25307-25312
42. Vetvicka V (2011) Glucan - immunostimulant, adjuvant, potential drug. World J Clin Oncol 2:115-119